Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

BOSTON SCIENTIFIC CORPORATION (BSX)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Boston Scientific : Health Care Up On Earnings Optimism -- Health Care Roundup

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/09/2018 | 10:08pm CEST

Shares of health-care companies rose amid optimistic earnings expectations. Shares of medical-device maker Boston Scientific Corp. (>> Boston Scientific Corporation) rallied after it said it expects to report a roughly 10% increase in fourth-quarter revenue. A new Eli Lilly & Co. (>> Eli Lilly and Company) research executive said the drug maker plans to make some riskier bets on deals for experimental drugs developed by other companies, capitalizing on research-and-development cutbacks by larger competitors, The Wall Street Journal reported.

-Rob Curran, [email protected]

Stocks mentioned in the article : Boston Scientific Corporation, Eli Lilly and Company
Stocks mentioned in the article
ChangeLast1st jan.
ELI LILLY AND COMPANY -0.87% 79.06 Delayed Quote.-5.58%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BOSTON SCIENTIFIC CORPORAT
04/20BOSTON SCIENTIFIC CORPORATION : quaterly earnings release
04/20LATEST RESEARCH ON GLOBAL DEFIBRILLA : Defibrillator Market Global Industry Anal..
AQ
04/19BOSTON SCIENTIFIC : An Application for the Trademark "MYLUX" Has Been Filed by B..
AQ
04/19BOSTON SCIENTIFIC : An Application for the Trademark "TYPHOONRFA" Has Been Filed..
AQ
04/18BOSTON SCIENTIFIC : acquires California-based women`s healthcare company, nVisio..
AQ
04/17BOSTON SCIENTIFIC : buys nVision Medical in $275M deal
AQ
04/16NEUROLOGY DEVICES MARKET TO GROW AT : Neurology Devices Market Analysis, Market..
AQ
04/16BOSTON SCIENTIFIC : Prevails In European Patent Dispute With Edwards Lifescience..
PR
04/16BOSTON SCIENTIFIC : Announces Acquisition Of nVision Medical Corporation
PR
04/13GLOBAL MI NEUROSURGERY DEVICES MARKE : Key Players profiled in this report are M..
AQ
More news
News from SeekingAlpha
04/20Key events next week - healthcare 
04/16Boston Scientific acquires nVision Medical for up to $275M 
04/04VALUATION DASHBOARD : Healthcare - Update 
04/03Boston Scientific acquires remaining stake in Securus Medical for up to $50M 
03/28Boston Scientific prevails over Edwards in UK patent dispute 
Financials ($)
Sales 2018 9 748 M
EBIT 2018 2 437 M
Net income 2018 1 375 M
Debt 2018 4 017 M
Yield 2018 -
P/E ratio 2018 28,75
P/E ratio 2019 24,46
EV / Sales 2018 4,49x
EV / Sales 2019 4,10x
Capitalization 39 785 M
Chart BOSTON SCIENTIFIC CORPORAT
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Technical analysis trends BOSTON SCIENTIFIC CORPORAT
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 31,8 $
Spread / Average Target 10%
EPS Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
John Bradley Sorenson Senior Vice President-Manufacturing & Supply Chain
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian T. Meredith Global Chief Medical Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORPORATION16.54%39 785
THERMO FISHER SCIENTIFIC13.70%86 857
DANAHER CORPORATION9.18%70 780
INTUITIVE SURGICAL25.03%51 587
ROYAL PHILIPS4.41%38 068
ILLUMINA12.52%35 894